- Previous Close
2,686.00 - Open
2,679.00 - Bid 2,716.00 x --
- Ask 2,717.00 x --
- Day's Range
2,675.00 - 2,718.00 - 52 Week Range
2,551.00 - 5,034.00 - Volume
64,153 - Avg. Volume
123,501 - Market Cap (intraday)
3.794B - Beta (5Y Monthly) 0.83
- PE Ratio (TTM)
1,627.54 - EPS (TTM)
1.67 - Earnings Date Feb 25, 2025
- Forward Dividend & Yield 1.10 (4.05%)
- Ex-Dividend Date Apr 10, 2025
- 1y Target Est
--
Croda International Plc engages in the consumer care, life science, and industrial specialty businesses in Europe, the Middle East, Africa, North America, Asia, and Latin America. The company offers consumer care products across beauty care, beauty actives, and home care products, as well as fragrances and flavours. It also provides biologics drug delivery, crop protection, and seed coating systems and enhancement technologies to improve germination. In addition, the company offers industrial specialties, including phase change materials; surfactants, such as emulsifiers, dispersants, wetting agents, detergents, and polymerics; and formulated textile and spin finishes. Croda International Plc was incorporated in 1925 and is headquartered in Goole, the United Kingdom.
www.croda.com6,027
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: CRDAL.XC
View MorePerformance Overview: CRDAL.XC
Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CRDAL.XC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CRDAL.XC
View MoreValuation Measures
Market Cap
3.78B
Enterprise Value
4.32B
Trailing P/E
16.24
Forward P/E
17.21
PEG Ratio (5yr expected)
1.26
Price/Sales (ttm)
2.33
Price/Book (mrq)
1.66
Enterprise Value/Revenue
2.65
Enterprise Value/EBITDA
11.52
Financial Highlights
Profitability and Income Statement
Profit Margin
9.73%
Return on Assets (ttm)
4.09%
Return on Equity (ttm)
6.84%
Revenue (ttm)
1.63B
Net Income Avi to Common (ttm)
158.5M
Diluted EPS (ttm)
1.67
Balance Sheet and Cash Flow
Total Cash (mrq)
166.8M
Total Debt/Equity (mrq)
30.44%
Levered Free Cash Flow (ttm)
122.56M